Life Sciences

Extending and improving lives

We seek to build and invest in the most promising companies across the cell therapy space.

Our investment focus


We build and invest from pre-seed through to Series A


London, Basel, Cambridge

Strategic Focus Area

Cell therapy (therapeutics, services and manufacturing technologies)

Our thesis

Cell therapy represents one of the most important therapeutic paradigms emerging to treat some of our most pernicious diseases. It is not only upending how patients are treated, but is also disrupting the way therapies are developed, manufactured, and delivered to patients – which creates new unmet needs and exciting business opportunities.

Delin’s goal is to position itself at the nexus of this opportunity, being the pre-eminent investor in promising cell therapies and the infrastructure that enables their development and commercialization.